Emilio de la Guardia to join UV Clinical as investor and member of the Board

Today it is our privilege to announce that Emilio de la Guardia has joined UV Clinical as an investor and as a member of the Board of Directors of the company. 
With a double degree in law and history from the University of Navarra, an MBA from McGill University, and a Master’s in EEC Law from the College of Europe in Bruges, Belgium, Emilio has over 30 years of working experience with the European Investment Bank, EIB. He has also worked extensively as a private equity investor and a start-up entrepreneur, founder, and principal. He is currently a member of the Board of Directors of several industrial companies and investment funds.
As a seasoned executive in the European financial sector, Emilio is bringing essential new financial and strategic competencies to the Board of Directors. We are really excited to welcome Emilio to our company and to work with him to develop UV Clinical to its full potential.


More Posts

Biofilm formation in endotracheal tubes

It is well-known from in-vitro experiments and analysis of catheters and endotracheal tubes (ET tubes) removed from patients, such as, that microorganisms settle on surfaces and form a biofilm within 24 hours.

Send Us A Message